Charles River Laboratories Announces Planned Retirement of James C. Foster and CEO Succession Plan

About this update from Charles River Laboratories International, Inc.

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1245,"height":326,"url":"https://media.zenfs.com/en/business-wire.com/3f1c2c8b12a101c79de25363b4c83f9d"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/dOVy7dlASkT.cLHAafSbvA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTI1MTtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/3f1c2c8b12a101c79de25363b4c83f9d","width":960,"height":251},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/lu9kVnM7ERxhH1gMLXuj3Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD02Mjg7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/3f1c2c8b12a101c79de25363b4c83f9d","width":1200,"height":314}},"lazy":false},{"type":"text","content":"– Jim Foster, Chair, President & CEO, Announces Plans to Retire at the 2026 Annual Meeting of Shareholders in May 2026 After Distinguished 50-Year Career at Charles River –","length":176,"tagName":"p","attribs":{}},{"type":"text","content":"– Birgit Girshick, Current Executive Vice President & COO, Unanimously Appointed Next Chief Executive Officer, Also Effective in May 2026 –","length":143,"tagName":"p","attribs":{}},{"type":"text","content":"WILMINGTON, Mass., January 08, 2026--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) announced today that James C. (Jim) Foster, Chair, President, and Chief Executive Officer (CEO), plans to retire, effective on May 5, 2026 at the conclusion of the 2026 Annual Meeting of Shareholders. The Company’s Board of Directors (Board) has unanimously appointed Birgit Girshick, current Executive Vice President and Chief Operating Officer (COO), as the next CEO, concurrent with Mr. Foster’s planned retirement in May. Ms. Girshick has also been nominated by the Board to be a Director effective at the 2026 Annual Meeting.","length":643,"tagName":"p"},{"type":"text","content":"Mr. Foster will remain on Charles River’s Board as a non-executive Director, and Martin Mackay, Ph.D., current Lead Independent Director, will become Chair of the Board at the conclusion of the 2026 Annual Meeting. These appointments are the result of a comprehensive, Board-led succession process designed to ensure long-term continuity, stability, and strategic alignment and reflect the Board’s confidence in Ms. Girshick as the right leader to guide Charles River th...

More updates from Charles River Laboratories International, Inc.